Titan Pharmaceuticals, Inc. (TTNP)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 6.31M |
| Enterprise Value | 114.12k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.19k |
| Price/Book (mrq) | 0.95 |
| Enterprise Value/Revenue | 7.04 |
| Enterprise Value/EBITDA | -0.92 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.33 |
| 52-Week Change 3 | -56.84% |
| S&P500 52-Week Change 3 | 26.43% |
| 52 Week High 3 | 16.60 |
| 52 Week Low 3 | 5.00 |
| 50-Day Moving Average 3 | 7.16 |
| 200-Day Moving Average 3 | 7.91 |
Share Statistics
| Avg Vol (3 month) 3 | 7.16k |
| Avg Vol (10 day) 3 | 2.31k |
| Shares Outstanding 5 | 914.23k |
| Implied Shares Outstanding 6 | 914.23k |
| Float 8 | 699.98k |
| % Held by Insiders 1 | 45.47% |
| % Held by Institutions 1 | 5.41% |
| Shares Short (Apr 15, 2024) 4 | 10.18k |
| Short Ratio (Apr 15, 2024) 4 | 0.67 |
| Short % of Float (Apr 15, 2024) 4 | 1.37% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 1.11% |
| Shares Short (prior month Mar 15, 2024) 4 | 12.04k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Dec 01, 2020 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:20 |
| Last Split Date 3 | Jan 09, 2024 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -3,954.89% |
Management Effectiveness
| Return on Assets (ttm) | -74.90% |
| Return on Equity (ttm) | -139.14% |
Income Statement
| Revenue (ttm) | 184k |
| Revenue Per Share (ttm) | 0.25 |
| Quarterly Revenue Growth (yoy) | -100.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -7.17M |
| Net Income Avi to Common (ttm) | -5.57M |
| Diluted EPS (ttm) | -7.41 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.76M |
| Total Cash Per Share (mrq) | 7.39 |
| Total Debt (mrq) | 565k |
| Total Debt/Equity (mrq) | 8.51% |
| Current Ratio (mrq) | 5.55 |
| Book Value Per Share (mrq) | 8.50 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7.09M |
| Levered Free Cash Flow (ttm) | -5.65M |
© 2024 Yahoo. All rights reserved.